Influenza vaccination and mortality:: prospective cohort study of the elderly in a large geographical area

被引:48
作者
Oertqvist, A. [1 ]
Granath, F.
Askling, J.
Hedlund, J.
机构
[1] Karolinska Univ Hosp, Dept Communicable Dis Control & Prevent, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Clin Epidemiol Unit, Solna, Sweden
[3] Karolinska Inst, Dept Med, Infect Dis Unit, Solna, Sweden
关键词
D O I
10.1183/09031936.00135306
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The 50% reduced overall mortality previously associated with influenza vaccination among the elderly was based on studies neither fully taking into account systematic differences between individuals who accept or decline vaccination nor encompassing the entire general population. A population-based prospective cohort study was performed in Stockholm County (Sweden), including all persons aged >= 65 yrs (n=similar to 260,000), over three influenza seasons: 1998/1999, 1999/2000 and 2000/2001. The relative risks of mortality among vaccinated versus unvaccinated individuals were estimated using Cox's proportional hazards regression adjusted for, and stratified by, demographic factors and comorbid conditions during the three seasons and the respective following off-seasons. Influenza vaccination was associated with an unadjusted reduction in all-cause mortality during the three seasons of 50, 46 and 42%, respectively, which decreased to 14, 19 and 1%, respectively, following adjustment for confounders and differences in mortality between vaccinated and unvaccinated individuals following the influenza season. The numbers needed to treat to prevent one death, during the three seasons, were 297, 158 and 743, respectively. Vaccination remains the most important measure for prevention of influenza complications in elderly people, although the effectiveness in reducing all-cause mortality in elderly persons islower than previously thought.
引用
收藏
页码:414 / 422
页数:9
相关论文
共 20 条
[11]   The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses [J].
Melegaro A. ;
Edmunds W.J. .
European Journal of Epidemiology, 2004, 19 (4) :353-363
[12]   Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly [J].
Nichol, KL ;
Nordin, J ;
Mullooly, J ;
Lask, R ;
Fillbrandt, K ;
Iwane, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1322-1332
[13]   Influenza and the winter increase in mortality in the United States, 1959-1999 [J].
Reichert, TA ;
Simonsen, L ;
Sharma, A ;
Pardo, SA ;
Fedson, DS ;
Miller, MA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (05) :492-502
[14]   THE PROTECTIVE EFFICACY OF POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE [J].
SHAPIRO, ED ;
BERG, AT ;
AUSTRIAN, R ;
SCHROEDER, D ;
PARCELLS, V ;
MARGOLIS, A ;
ADAIR, RK ;
CLEMENS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1453-1460
[15]   The impact of influenza epidemics on mortality: Introducing a severity index [J].
Simonsen, L ;
Clarke, MJ ;
Williamson, GD ;
Stroup, DF ;
Arden, NH ;
Schonberger, LB .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (12) :1944-1950
[16]   Impact of influenza vaccination on seasonal mortality in the US elderly population [J].
Simonsen, L ;
Reichert, TA ;
Viboud, C ;
Blackwelder, WC ;
Taylor, RJ ;
Miller, MA .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (03) :265-272
[17]   IMPACT OF INFLUENZA ON MORTALITY IN RELATION TO AGE AND UNDERLYING DISEASE, 1967-1989 [J].
SPRENGER, MJW ;
MULDER, PGH ;
BEYER, WEP ;
VANSTRIK, R ;
MASUREL, N .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1993, 22 (02) :334-340
[18]   Treatment and prevention of influenza: Swedish recommendations [J].
Uhnoo, I ;
Linde, A ;
Pauksens, K ;
Lindberg, A ;
Eriksson, M ;
Norrby, R .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (01) :3-11
[19]   Annual revaccination against influenza and mortality risk in community-dwelling elderly parsons [J].
Voordouw, ACG ;
Sturkenboom, MCJM ;
Dieleman, JP ;
Stijnen, T ;
Smith, DJ ;
van der Lei, J ;
Stricker, BHC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (17) :2089-2095
[20]   A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community [J].
Vu, T ;
Farish, S ;
Jenkins, M ;
Kelly, H .
VACCINE, 2002, 20 (13-14) :1831-1836